Psychedelic medicine's moment has arrived – Israel should not sit it out

For decades, psychedelic compounds occupied an uncomfortable place in medicine. Scientists were intrigued, patients were searching for new options, and regulators remained cautious. That is changing. On April 18, President Donald Trump signed an executive order that explicitly includes ibogaine compounds and directs federal agencies to accelerate research and explore a lawful Right to Try […] The…